These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 12920411

  • 1. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED.
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [Abstract] [Full Text] [Related]

  • 2. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
    Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H, Mirtazapine in the Nursing Home Study Group.
    Curr Med Res Opin; 2003 Aug; 19(8):737-46. PubMed ID: 14687445
    [Abstract] [Full Text] [Related]

  • 3. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
    van Moffaert M, de Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J.
    Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801
    [Abstract] [Full Text] [Related]

  • 4. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J, Barkin RL.
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [Abstract] [Full Text] [Related]

  • 5. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS, Ng F, Berk M.
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial.
    Chung MY, Min KH, Jun YJ, Kim SS, Kim WC, Jun EM.
    Hum Psychopharmacol; 2004 Oct; 19(7):489-94. PubMed ID: 15378676
    [Abstract] [Full Text] [Related]

  • 7. Efficacy, tolerability, and preference of mirtazapine orally disintegrating tablets in depressed patients: a 17-week naturalistic study in Lithuania.
    Danileviciūte V, Sveikata A, Adomaitiene V, Gumbrevicius G, Fokas V, Sveikatiene R.
    Medicina (Kaunas); 2009 Oct; 45(10):778-84. PubMed ID: 19996664
    [Abstract] [Full Text] [Related]

  • 8. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
    Smith WT, Glaudin V, Panagides J, Gilvary E.
    Psychopharmacol Bull; 1990 Oct; 26(2):191-6. PubMed ID: 2236455
    [Abstract] [Full Text] [Related]

  • 9. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
    Varia I, Venkataraman S, Hellegers C, Gersing K, Doraiswamy PM.
    Psychopharmacol Bull; 2007 Oct; 40(1):47-56. PubMed ID: 17285095
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
    Kim SW, Shin IS, Kim JM, Kim YC, Kim KS, Kim KM, Yang SJ, Yoon JS.
    Psychiatry Clin Neurosci; 2008 Feb; 62(1):75-83. PubMed ID: 18289144
    [Abstract] [Full Text] [Related]

  • 11. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A, Crawford GM, Angus M, Wilson R, Hamilton L.
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [Abstract] [Full Text] [Related]

  • 12. Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and older.
    Nelson JC, Hollander SB, Betzel J, Smolen P, Mirtazapine Nursing Home Study Group.
    Int J Geriatr Psychiatry; 2006 Sep; 21(9):898-901. PubMed ID: 16955423
    [Abstract] [Full Text] [Related]

  • 13. Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study.
    Saiz-Ruiz J, Montes JM, Ibáñez A, Díaz M, Vicente F, Pelegrín C, Viñas R, Arias F, Carrasco JL, Ferrando L.
    Hum Psychopharmacol; 2005 Aug; 20(6):435-40. PubMed ID: 16106478
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 15. Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
    Benkert O, Szegedi A, Philipp M, Kohnen R, Heinrich C, Heukels A, van der Vegte-Senden M, Baker RA, Simmons JH, Schutte AJ.
    J Clin Psychopharmacol; 2006 Feb; 26(1):75-8. PubMed ID: 16415711
    [Abstract] [Full Text] [Related]

  • 16. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G.
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
    [Abstract] [Full Text] [Related]

  • 17. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
    Kim JE, Yoon SJ, Kim J, Jung JY, Jeong HS, Cho HB, Shin E, Lyoo IK, Kim TS.
    Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E, Skarstein J, Behnke K, Agren H, Helsdingen JT.
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [Abstract] [Full Text] [Related]

  • 20. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
    Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S, Mirtazapine-Venlafaxine Study Group.
    J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.